Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
September 29, 2025

Investigating the Role of Cancer-Associated Fibrob...

Emily Bernstein‘s Abstract Melanoma is the most lethal skin cancer, and the success of current therapies remains limited. To better tailor melanoma treatments, we m...

2 Minute Read
September 29, 2025

Pedigree Approach to Identify Predisposition Varia...

Lisa Cannon-Albright‘s Abstract Analysis of large families with more disease than expected has been shown to be a powerful way to identify cancer predisposition g...

2 Minute Read
September 29, 2025

Redirecting Antiviral Immune Responses to Elimina...

Thorsten Mempel‘s Abstract While immunotherapy has greatly improved the survival for patients with melanoma of the sun-exposed skin, especially for those with adva...

3 Minute Read
September 29, 2025

 Inhibiting ligand-driven BMP Signaling to Overco...

Craig Ceol‘s Abstract The use of immunotherapies has revolutionized treatment for late-stage melanoma patients. These therapies have extended survival for many patien...

3 Minute Read
December 18, 2024

UV-Induced Epigenetic Changes in the Epidermis in ...

Elena Ezhkova’s Abstract Melanoma is an aggressive type of skin cancer with a low survival rate when it metastasizes. Melanoma originates mainly in sun-exposed areas,...

2 Minute Read
December 18, 2024

ADAR1 Inhibitor: Novel Therapeutic for Melanoma &a...

Kazuko Nishikura’s Abstract The phenomenon of “RNA editing” is a relatively recent discovery with exciting implications. RNA editing is a process that modifies th...

3 Minute Read
December 19, 2023

NKT infiltration and rejection in melanomas

Current immunotherapies have dramatically improved clinical outcomes, but more than half of metastatic melanoma patients have poor responses and primary resistance. With ti...

1 Minute Read
December 19, 2023

TGFßi NK Cell Infusions in Patients with Melanoma...

Brain metastases remain a leading cause of death in patients with metastatic melanoma. One of the most exciting advances in the treatment of CNS metastases was combined che...

2 Minute Read
December 19, 2023

Targeting an adaptor function of CDK6 to enhance m...

Immunotherapy has been remarkably successful in the treatment of melanoma, but not all patients benefit from therapy and its effects is in most cases temporary, followed by...

1 Minute Read
December 19, 2022

Biomarkers to Predict Melanoma Patient Immunothera...

Our immune system operates on a balance of cells that that can destroy infected or cancerous tissue with those that prevent attacking healthy tissue. This equilibrium is af...

2 Minute Read
December 19, 2022

Role of the Gli2 Pathway in Melanoma Immunotherapy...

While immunotherapy has revolutionized the management of advanced melanoma, many patients still do not benefit from this treatment strategy. Indeed, currently available imm...

2 Minute Read
December 19, 2022

Noncanonical Autophagy Inhibition as a New Approac...

Cancer treatment was revolutionized when scientists discovered how to activate a patients’ own immune system to fight tumors. Unfortunately, some patients have tumors tha...

3 Minute Read

Oct 16, 2025 ET

5th Annual #GetNakedJax

Oct 16, 2025 ET

Ask the Expert: Mucosal Melanoma – Current and Emerging Treatments, Research and Patient Perspectives

Oct 18, 2025 ET

San Diego Miles for Melanoma 5K

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

24th Annual New York Gala

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Nov 02, 2025 ET

Atlanta Miles for Melanoma 5K

Explore Events